Moderna, Inc. (MRNA) Financials
MRNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 11.5 billion | 4.1 billion |
| Dec. 31, 2025 | 12.3 billion | 3.7 billion |
| Sept. 30, 2025 | 12.1 billion | 2.8 billion |
| June 30, 2025 | 12.0 billion | 2.6 billion |
MRNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -692.0 million | 104.0 million |
| Dec. 31, 2025 | 912.0 million | 113.0 million |
| Sept. 30, 2025 | -880.0 million | 125.0 million |
| June 30, 2025 | -922.0 million | 130.0 million |
MRNA Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | -1.3 billion |
| Dec. 31, 2025 | -826.0 million |
| Sept. 30, 2025 | -200.0 million |
| June 30, 2025 | -825.0 million |
MRNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 5.2 billion | 590.0 million | 658.0 million |
| Dec. 31, 2025 | 5.8 billion | 1.2 billion | 673.0 million |
| Sept. 30, 2025 | 4.5 billion | 660.0 million | 686.0 million |
| June 30, 2025 | 5.1 billion | - | 741.0 million |
MRNA Shares Outstanding
MRNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 62.0 million | 649.0 million | 173.0 million | - |
| Dec. 31, 2025 | 39.0 million | 775.0 million | 308.0 million | - |
| Sept. 30, 2025 | 33.0 million | 801.0 million | 268.0 million | - |
| June 30, 2025 | 3.0 million | 700.0 million | 230.0 million | - |
MRNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 389.0 million | 955.0 million |
| Dec. 31, 2025 | 678.0 million | 452.0 million |
| Sept. 30, 2025 | 1.0 billion | 1.0 billion |
| June 30, 2025 | 142.0 million | 119.0 million |
MRNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MRNA
Price: $54.05
52 week price:
Payout Ratio Range:
Earnings Per Share: -8.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.3 million
Market Capitalization: 31.6 billion